Results 201 to 210 of about 9,557,066 (249)

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, Volume 38, Issue 61, 2 November 2026.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Scalable Fabrication of Chemically Stabilized Gelatin Hydrogel Fibers by Thermal Drawing

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 22, 17 November 2026.
Scalable processing of hydrogel fibers remains a major challenge. By coupling thermal drawing with Maillard chemistry, a transient viscous‐flow window is created that enables continuous fabrication of microstructured gelatin fibers tens of meters long, while continued in situ crosslinking during drawing stabilizes the fibers for physiological ...
Chaoqun Dong   +5 more
wiley   +1 more source

Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9‐CD36 Axis in Obesity‐Associated Pancreatic Adenocarcinoma

open access: yesAdvanced Science, Volume 13, Issue 62, 9 November 2026.
Pancreatic adenocarcinoma (PAAD) remains highly lethal with limited treatment options. This study demonstrates that coixenolide, a bioactive compound from Coix lacryma‐jobi L. and a key component of the clinically approved Kanglaite injection, exhibits enhanced antitumor efficacy in high‐fat diet (HFD)‐induced obese mice bearing PAAD tumors compared to
Kaidi Chen   +20 more
wiley   +1 more source

Arthroscopic Images Predict Tendon Integrity After Arthroscopic Rotator Cuff Repair Using a Deep Learning Model

open access: yesArthroscopy, Volume 42, Issue 11, Page 2394-2404, November 2026.
Purpose To assess the feasibility of a deep learning model for predicting early structural integrity after arthroscopic rotator cuff repair (ARCR) using intraoperative arthroscopic images obtained after the double‐row bridging repair technique. Methods This retrospective study included patients who underwent ARCR between January 2016 and June 2024 ...
Kuan‐Ting Wu   +5 more
wiley   +1 more source

Exploring Eugenia brasiliensis Leaves as a Natural Source for Anti‐Aging, Skin Protection, and Phytocosmetic Applications

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
ABSTRACT The aim of this study was to evaluate the chemical composition and the in vitro anti‐aging and skin‐protective properties of the crude hydroalcoholic extract (CHE) and fractions of Eugenia brasiliensis, known as “grumixama”, for potential phytocosmetic applications.
Raquel Oppermann   +14 more
wiley   +1 more source

Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis

open access: yesCell Biochemistry and Function, Volume 44, Issue 11, November 2026.
ABSTRACT Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and ...
Weiwei Jiang, Haiping Du
wiley   +1 more source

Advanced Glycation End-Products and the Kidney [PDF]

open access: yesEuropean Journal of Clinical Investigation, 2010
Eur J Clin Invest 2010; 40 (8): 742–755AbstractBackground Advanced glycation end‐products (AGEs) are increased in situations with hyperglycemia and oxidative stress such as diabetes mellitus. They are products of nonenzymatic glycation and oxidation of proteins and lipids.
Martin Busch   +2 more
exaly   +3 more sources

Advanced glycation end products in uremia

Advances in Renal Replacement Therapy, 2003
The term "advanced glycation end products" (AGEs) stands for a heterogeneous group of amino acid derivatives that are formed via glycation processes between peptide-bound lysine or arginine derivatives and carbonyl compounds, processes originally known from food systems as "Maillard reactions." AGEs accumulate in plasma and tissues with advancing age ...
Thomas, Henle, Toshio, Miyata
openaire   +2 more sources

Advanced Glycation End Products and Its Receptor (RAGE) Are Increased in Patients With COPD

open access: yesRespiratory Medicine, 2011
SummaryAdvanced Glycation End products (AGEs) are the products of nonenzymatic glycation and oxidation of proteins and lipids. Formation of AGEs is increased in response to hyperglycaemia, reactive oxygen species and ageing.
Louise Nicholson, Peter Black, Lian Wu
exaly   +2 more sources

Advanced glycation end products and the kidney

American Journal of Physiology-Renal Physiology, 2005
Advanced glycation end products (AGEs) are a heterogeneous group of protein and lipids to which sugar residues are covalently bound. AGE formation is increased in situations with hyperglycemia (e.g., diabetes mellitus) and is also stimulated by oxidative stress, for example in uremia.
Jürgen M, Bohlender   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy